Eloxx Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ELOX, updated each market day.
ELOX AI Sentiment
Check back on the next market day for an updated Eloxx Pharmaceuticals, Inc. Common Stock prediction.
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Sector
Exchange
Market Cap
$53,281,258
Cap Tier
Employees
7
Headquarters
ARLINGTON, MA
Listed Since
Dec. 11, 1998
